We take a look at Faron's year 2025 and evaluate whether the Second Tranche Bond was a rational choice when compared with alternatives available under the short runway.
Faron Pharmaceuticals — Death Spiral Deepens
We take a look at Faron's year 2025 and evaluate whether the Second Tranche Bond was a rational choice when compared with alternatives available under the short runway.